Pregnancy Clinical Trial
Official title:
Perinatal Effects of Mindfulness Phone App Use in Pregnancy (PaMPPr Study)
There is evidence to show that mindful meditation has a positive impact on health. To date, all the studies done to investigate the effect of mindfulness on pregnancy outcomes have been done through a traditional 8-10 weeks mindfulness classroom program with some home practice. This time-intensive classroom training may be expensive and not convenient for many busy pregnant women. This study will investigate the use of a smartphone app-based intervention to determine if it has the potential to make mindfulness training more accessible, acceptable, and convenient to a larger number of pregnant women. The use of an app as opposed to traditional structured classes may increase a woman's ability and willingness to practice mindfulness because the app can be used almost anywhere and at any time. This pilot study aims to explore the feasibility and acceptability of a smartphone mindfulness meditation application for pregnant women. As well, this study will compare the pregnancy outcomes of women who use the app to those women who do not use the app.
This is a randomised controlled trial to study the effect of the use of a mindfulness
meditation app on pregnancy outcomes. This study will measure how often the app is used, as
well as indicators of maternal health such as sleep, stress, depression, anxiety and other
perinatal outcomes (premature delivery, diabetes during pregnancy (gestational diabetes),
high blood pressure in pregnancy (hypertensive disorders of pregnancy), inadequate growth of
the baby inside the womb (fetal growth restriction), bleeding in later pregnancy, mode of
delivery, pain relief during delivery, length of stay for mother and baby in the hospital,
admission of baby in ICU, pain relief medication requirement after delivery, and
breastfeeding).
Participants will be randomly assigned to either group A (the experimental group) or group B
(the control group). All participants will be given a an actigraph to measure sleep.
Participants in Group A will be given a free subscription to a mindfulness meditation app for
six months. They will also be given a general pregnancy sleep leaflet. Participants assigned
to Group B will be given the general pregnancy sleep leaflet only.
There will be 3 visits associated with this study. At each of the 3 visits, participants will
be given four questionnaires to complete - the Pittsburgh Sleep Quality Index, Perceived
Stress Questionnaire, Beck's Anxiety Inventory, and the Edinburgh Postnatal Depression Scale.
Participants in Group A will also be asked to complete a fifth survey at their post-partum
visit. This survey will collect information on how easy it was to use the mindfulness
meditation app.
Information on delivery outcomes will also be collected. This information will include things
such as any complications that occur during delivery, baby's birth weight and Apgar score,
any complications with baby's health, method of delivery, and pain medications used during
delivery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |